-
Posted: 12/5/2011 7:48:35 AM EST
German Finance Minister Wolfgang Schaeuble speaks after receiving the title of Honorary Doctor of Corvinus University in Budapest December 5, 2011. Federal budgets of those euro zone countries that fail to meet the bloc's requirements should be rejected, Schaeuble said on Monday. REUTERS/Laszlo Balogh (HUNGARY - Tags: BUSINESS EDUCATION POLITICS)
-
Posted: 12/2/2011 10:31:15 PM EST
Columbus Blue Jackets goalie Curtis Sanford (L) and Nikita Nikitin (R, bottom) fail to stop Edmonton Oilers' Jordan Eberle (not pictured) and Shawn Horcoff (R, top) from scoring during the first period of their NHL hockey game in Edmonton December 2, 2011. REUTERS/Dan Riedlhuber (CANADA - Tags: SPORT ICE HOCKEY TPX IMAGES OF THE DAY)
-
Posted: 12/1/2011 8:39:24 AM EST
Ed Damiano (R) shows the insulin infusion set which delivers insulin to his son David, at the family's home in Acton, Massachusetts July 23, 2011. Damiano, whose 12-year-old son David was diagnosed with type 1 diabetes when he was 11 months-old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. REUTERS/Brian Snyder
-
Posted: 12/1/2011 8:34:02 AM EST
Ed Damiano (R) shows the insulin infusion set which delivers insulin to his son David, at the family's home in Acton, Massachusetts July 23, 2011. Damiano, whose 12-year-old son David was diagnosed with type 1 diabetes when he was 11 months-old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. REUTERS/Brian Snyder
-
Posted: 12/1/2011 12:51:55 AM EST
Ed Damiano (R) watches his 12 year-old son David, who was diagnosed with type 1 diabetes when he was 11 months old, climb the swingset in the family's backyard in Acton, Massachusetts July 23, 2011. Damiano is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:49:31 AM EST
David Damiano, 12, who was diagnosed with type 1 diabetes when he was 11 months old, swims in the family's backyard pool in Acton, Massachusetts July 23, 2011. David's father Ed is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:47:40 AM EST
Ed Damiano uses an iPad in the family's kitchen in Acton, Massachusetts to remotely monitor the glucose of a study subject in real time July 23, 2011. Damiano, whose 12 year-old son David was diagnosed with type 1 diabetes at 11 months old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:46:03 AM EST
David Damiano, 12, who was diagnosed with type 1 diabetes when he was 11 months old, swims in the family's backyard pool in Acton, Massachusetts July 23, 2011. David's father Ed is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:44:03 AM EST
Ed Damiano (front) checks the receiver for the Navigator glucose monitor worn by his 12 year-old son David (rear), who was diagnosed with type 1 diabetes when he was 11 months old, in Acton, Massachusetts July 23, 2011. Damiano is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:39:43 AM EST
David Damiano (R), 12, who was diagnosed with type 1 diabetes when he was 11 months old, pours himself a drink after his glucose levels dropped, in the kitchen with his mother Toby (L) in Acton, Massachusetts July 23, 2011. His father Ed, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:37:25 AM EST
Ed Damiano checks the receiver for the Navigator glucose monitor worn by his 12 year-old son David (rear), who was diagnosed with type 1 diabetes when he was 11 months old, in Acton, Massachusetts July 23, 2011. Damiano is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:35:51 AM EST
Ed Damiano pushes his son David on a swing in the family's backyard in Acton, Massachusetts July 23, 2011. Damiano, whose 12-year-old son David was diagnosed with type 1 diabetes when he was 11 months old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:28:09 AM EST
Dr. Steven Russell remotely checks the the glucose levels of a study subject in real time from his car in Acton, Massachusetts, before heading to the hospital to meet the subject July 23, 2011. Dr. Russell is working with Ed Damiano, whose 12 year-old son David was diagnosed with type 1 diabetes when he was 11 months old, to develop a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:25:45 AM EST
Ed Damiano holds up the prototype for the portable monitor for a bionic pancreas at the family's home in Acton, Massachusetts, July 23, 2011. Damiano, whose 12 year-old son David (rear) was diagnosed with type 1 diabetes when he was 11 months old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Analysis DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:24:11 AM EST
David Damiano, 12, who was diagnosed with type 1 diabetes when he was 11 months old, plays on the swingset in the family's backyard in Acton, Massachusetts July 23, 2011. David's father Ed Damiano is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:22:03 AM EST
Ed Damiano points to the continuous glucose monitor on his son David's leg at the family's home in Acton, Massachusetts July 23, 2011. Damiano, whose 12 year-old son David was diagnosed with type 1 diabetes when he was 11 months-old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:19:51 AM EST
Ed Damiano (R) shows the needle on the insulin infusion set which delivers insulin to his son, at the family's home in Acton, Massachusetts July 23, 2011. Damiano, whose 12 year-old son David was diagnosed with type 1 diabetes when he was 11 months-old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. To match Insight DIABETES/ Picture taken July 23, 2011. REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 12/1/2011 12:18:07 AM EST
Ed Damiano (R) shows the insulin infusion set which delivers insulin to his son David, at the family's home in Acton, Massachusetts July 23, 2011. Damiano, whose 12-year-old son David was diagnosed with type 1 diabetes when he was 11 months-old, is working on a bionic pancreas that will automatically control blood glucose in people with type 1 diabetes. That technology could make a major difference to the three million Americans with the disease who must vigilantly monitor their blood sugar, even at night, and risk deadly consequences if they fail to notice a dangerous change in time. A fresh confrontation is about to break open this week as the U.S. Food and Drug Administration lays out a path toward regulatory approval, expected as early as Thursday. Picture taken July 23, 2011. To match Insight DIABETES/ REUTERS/Brian Snyder (UNITED STATES - Tags: HEALTH SCIENCE TECHNOLOGY)
-
Posted: 11/22/2011 8:20:48 AM EST
Traders work on the floor of the New York Stock Exchange Monday, Nov. 21, 2011. Stocks are taking a sharp fall in early trading Monday amid reports that a congressional committee will fail to agree on a plan to cut the U.S. government's budget deficit.(AP Photo/Richard Drew)
-
Posted: 11/22/2011 8:20:48 AM EST
Specialists James Denaro, Christopher Culhane, and Glenn Carell, left to right, work on the floor of the New York Stock Exchange Monday, Nov. 21, 2011. Stocks are taking a sharp fall in early trading Monday amid reports that a congressional committee will fail to agree on a plan to cut the U.S. government's budget deficit.(AP Photo/Richard Drew)
